A Gene Therapy for Sickle Cell Disease has Been Approved for an Investigational New Drug Application by the FDA
The United States Food and Drug Administration has accepted an Investigational New Drug application (IND) for an investigational gene therapy designed to be a treatment for sickle cell disease. Previously,…